Envision Healthcare (NYSE:EVHC) posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.14, Bloomberg Earnings reports. The firm had revenue of $2 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Envision Healthcare had a positive return on equity of 4.62% and a negative net margin of 2.52%. The firm’s quarterly revenue was up 68.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.15 EPS. Envision Healthcare updated its Q1 guidance to $0.61 to $0.67 EPS and its FY18 guidance to $3.46 to $3.70 EPS.
Envision Healthcare (EVHC) traded down $3.31 during midday trading on Wednesday, hitting $39.41. The stock had a trading volume of 8,943,614 shares, compared to its average volume of 2,655,974. The firm has a market cap of $5,260.00, a price-to-earnings ratio of 18.19, a P/E/G ratio of 1.09 and a beta of 0.48. Envision Healthcare has a fifty-two week low of $23.77 and a fifty-two week high of $66.39. The company has a quick ratio of 3.38, a current ratio of 3.40 and a debt-to-equity ratio of 0.87.
A number of analysts have issued reports on the company. Robert W. Baird reissued an “outperform” rating and issued a $50.00 price target (up from $45.00) on shares of Envision Healthcare in a research note on Wednesday, March 7th. Mizuho set a $38.00 price target on Envision Healthcare and gave the stock a “hold” rating in a research note on Friday, March 2nd. Royal Bank of Canada reissued a “buy” rating and issued a $48.00 price target on shares of Envision Healthcare in a research note on Thursday, March 1st. SunTrust Banks raised their price target on Envision Healthcare to $45.00 and gave the stock a “buy” rating in a research note on Thursday, March 1st. Finally, Canaccord Genuity reissued a “buy” rating and issued a $46.00 price target (up from $32.00) on shares of Envision Healthcare in a research note on Wednesday, February 28th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and nine have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $42.57.
TRADEMARK VIOLATION WARNING: “Envision Healthcare (NYSE:EVHC) Releases Quarterly Earnings Results, Beats Estimates By $0.14 EPS” was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.thelincolnianonline.com/2018/03/14/envision-healthcare-evhc-issues-earnings-results.html.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.